Delfi is a Maryland-based biotechnology company that research and develops fluid biopsy tests for the early detection of cancer... Read more
Delfi is a Maryland-based biotechnology company that research and develops fluid biopsy tests for the early detection of cancer... Read more
News
May 12, 2025
Citybizlist
DELFI: DELFI Diagnostics CTO Dr. Amoolya Singh Recognized Among 2025 Most Influential Women in Bay Area Business
Apr 25, 2025
StreetInsider
Press Release: DELFI : DELFI Diagnostics to Present Early Detection and Advanced Cancer Monitoring Technology Updates at AACR Annual Meeting
Jan 08, 2025
StreetInsider
Press Release: DELFI : DELFI Diagnostics to Participate in J.P. Morgan Healthcare Conference
Oct 28, 2024
PR Newswire
Press Release: DELFI : DELFI Diagnostics Working with Incendia Therapeutics to Employ Advanced Treatment Monitoring Test in a Phase 1 Clinical Trial
Oct 07, 2024
StreetInsider
Press Release: DELFI : Allegheny Health Network explores use of promising new blood-based test to enhance lung cancer detection
Jun 03, 2024
STAT News
DELFI: STAT+: Delfi Diagnostics announces key data, study design for its liquid biopsy test
May 14, 2024
Medical Device Network
DELFI: OSF HealthCare collaborates with DELFI for lung cancer screening
Apr 02, 2024
Yahoo
DELFI: City of Hope and DELFI Diagnostics announce collaboration to improve lung cancer screening rates in underserved areas of Los Angeles
Feb 03, 2024
Pharmabiz
DELFI: DELFI Diagnostics introduces new fragmentomebased cancer treatment monitoring assay
Jan 05, 2024
Citybizlist
DELFI: DELFI Diagnostics Appoints Susan Tousi as Chief Executive Officer
